Business context and reporting period
Synalloy Corporation’s unaudited Form 10-Q covers the quarter and six months ended June 28, 2014. Continuing operations comprise the Metals and Specialty Chemicals segments. The planned closure of Bristol Fabrication (Bristol Fab) was completed June 27, 2014, and its results are reported as discontinued operations. The request metadata names ASCENT INDUSTRIES CO.; the filing itself identifies the registrant as Synalloy Corporation, a discrepancy investors should verify.
Financial and operating performance
| Metric | Three months ended June 28, 2014 | Six months ended June 28, 2014 |
|---|---|---|
| Continuing-operations sales | $58.8 million, up 10% | $111.7 million, up 4% |
| Gross profit / margin | $9.4 million / 15.9% | $17.3 million / 15.5% |
| Operating income / margin | $4.7 million / 8.0% | $8.4 million / 7.5% |
| Continuing-operations net income | $5.7 million; $0.66 diluted EPS | $8.0 million; $0.91 diluted EPS |
| Consolidated net income | $0.4 million | $2.2 million |
| Operating cash flow | $8.4 million for the six months, versus cash used of $2.2 million in the prior-year period |
Reported consolidated net income includes Bristol Fab discontinued-operations losses of $5.3 million for the quarter and $5.8 million for the six months. Continuing-operations pretax income also benefited from a $3.5 million gain from reducing the Palmer earn-out estimate. Interest expense was $0.5 million for the first six months, down from $0.7 million.
At June 28, cash was $6.1 million, current assets $108.4 million, and current liabilities $33.0 million. Total debt, including current maturities, was $22.2 million, down from $23.4 million at December 28, 2013. The company reported compliance with debt covenants. Six-month capital expenditures were $2.8 million, including $1.7 million for the CRI facility expansion.
Material changes versus prior comparable periods
- Metals Segment sales rose 7% in the quarter but fell 1% for the six months; segment operating income increased 115% and 102%, respectively. Management cited cost reductions, improved product mix and margins, lower inventory losses, and the completion of a low-margin nuclear project in 2013.
- Specialty Chemicals sales increased 17% in the quarter and 21% for the six months; operating income rose 7% and 16%. CRI Tolling, acquired in 2013, contributed $3.1 million of six-month revenue and $0.2 million of pretax earnings.
- Bristol Fab recorded $6.988 million of closure costs, including a $3.026 million noncash inventory disposal charge and about $1.9 million of pension-fund withdrawal liability. The unit had operating losses of $2.258 million in the first six months.
- Average diluted shares increased to 8.70 million from 6.43 million for the six-month comparison, following the September 2013 issuance of 2.3 million shares; this affects per-share comparisons.
Outlook, risks and unusual items
Management expected further improvement through the remainder of 2014, citing stronger quoting and project activity, continued focus on cost control and higher-margin product mix, and Specialty Chemicals growth opportunities. It expected Specialty Chemicals operating margins to hold steady and the CRI facility expansion to finish in late third quarter. Management noted strong special-alloy order activity and anticipated demand for Palmer tanks, while acknowledging that Metals demand depends substantially on customers’ capital spending. Backlog at June 28 was $17.4 million for fabrication (Ram-Fab only, following Bristol Fab’s closure) and $11.8 million for Palmer.
Key risks include demand and pricing volatility, raw-material availability and costs, nickel-price and inventory fluctuations, labor and staffing issues, customer financial condition or delays, energy-market and regulatory changes, acquisition integration, interest-rate exposure, and compliance with debt covenants. The company reported no material change in previously disclosed risk factors, no known legal matter expected to materially affect results, and effective disclosure controls. No formal numerical earnings guidance was provided.
Important facts for investors to verify
- Confirm the registrant identity: the filing is for Synalloy Corporation, although the request metadata names ASCENT INDUSTRIES CO.
- Assess the recurring earnings effect of Bristol Fab’s closure and distinguish continuing results from closure costs and discontinued operations.
- Review the assumptions behind the $3.5 million Palmer earn-out gain; the company expected no Year 2 payment and estimated a $2.5 million Year 3 payment.
- Monitor cash conversion and working capital: receivables increased about $7.5 million from year-end, while cash generation also reflected higher payables.
- Track debt, covenant headroom, CRI expansion spending, and the company’s exposure to raw-material prices and customer-driven demand.